Navigation Links
ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
Date:1/31/2008

TORONTO, Jan. 31 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that it has entered into a cGMP contract manufacturing agreement for its Trop-2 Signal Transduction Antibody Program with Laureate Pharma, a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. ARIUS' Trop-2 antibody program targets a novel marker that has been linked in the scientific literature to aggressive cancers including pancreatic, colon, breast and prostate cancer.

"The initiation of manufacturing for our second drug candidate demonstrates our ability to execute on our milestones and move multiple candidates from the ARIUS pipeline of drug candidates forward," said Dr. David S. Young, President and Chief Executive Officer of ARIUS. "Laureate Pharma has a track record of expertise in biopharmaceutical manufacturing, including capabilities in both clinical and commercial-grade materials and will provide us with a supply of our Trop-2 targeting drug necessary to begin our preclinical studies in the first quarter of 2008 in preparation for human clinical trials."

"Our specialized experience in the manufacture of monoclonal antibodies makes us an ideal partner to support ARIUS and the manufacturing of their Trop-2 Signal Transduction Antibody," said Robert J. Broeze, Ph.D., President & CEO of Laureate. "As with all of our Life Science client companies, we will work closely with the ARIUS team to help them achieve their manufacturing objectives."

ARIUS' Trop-2 Signal Transduction Antibody Program has produced the only unconjugated antibody currently in development targeting this novel marker. Trop-2 is a protein expressed on the cell-surface and found in many cancer indications including pancreatic, colon, breast and prostate cancer. The target is thought to be a key part of the expansive MAPK pathway.
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
2. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
3. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
4. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
5. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
8. ARIUS to present at Chinese Global Financial Forum
9. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
10. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
11. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MD (PRWEB) January 23, 2015 Portal ... modern digital workplaces on Microsoft Office 365 and SharePoint ... Future 50 Award program for being one of the region’s ... revenue and employee growth. , “To be recognized a ...
(Date:1/22/2015)... Jan. 22, 2015  Transwestern | RBJ today announces the firm ... space for Shire a leading biopharmaceutical company, at Two Ledgemont ... RBJ,s Robert Richards , president, and Brian Cohen ... the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Pipette.com has ... to their comprehensive portfolio of Eppendorf products. , ... to purchase a Centrifuge 5424/5424 R and receive the ... either Eppendorf Research plus or Eppendorf Reference 2 ...
(Date:1/22/2015)... January 22, 2015 Diagenode, Inc., ... as the Bioruptor® and complete solutions for epigenetics ... chromatin immunoprecipitation, alleviating the need for manual processing. ... needed for ChIP of histones or transcription factors ...
Breaking Biology Technology:Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 2Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 3Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... What and When, Additional results from the ... pioGlitazOne) published,today in Circulation revealed that reduced progression ... was,associated with increased levels of HDL cholesterol (HDL-C, ... increased effect on HDL-C levels at 24 weeks ...
... April 15 Pacira Pharmaceuticals, Inc. today,announced ... the,development of sustained release injectable products based ... companies will work,together to enhance the dosing ... development pipeline. The goal of the collaboration ...
... Inc.,(Nasdaq: BNVI ) will present findings on the ... and BN108 at the American Association of,Cancer Research (AACR) ... San,Diego, CA, April 12 - 16, 2008., Bionovo,s ... (cell death) induced by BN107 and BN108. As explained ...
Cached Biology Technology:New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl) 2New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl) 3Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R) 2Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research 2
(Date:1/22/2015)... Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication company ... of the Wocket™ smart wallet at CES 2015 in Las ... one of the "11 Hot Products at CES" in a review published ... Far" by Newseveryday.com and "The top 10 gadgets from CES 2015" by ...
(Date:1/22/2015)... EyeLock, Inc. , a market leader of iris-based identity authentication ... to the new role of Senior Vice President of Mobile ... mobile platforms and wearable solutions for EyeLock,s technologies. Gerber brings ... semiconductor industry to his role at EyeLock, with expertise in ...
(Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... do some microorganisms manage to exist and even thrive ... A team of scientists from the Weizmann Institute's Plant ... that a switch in just two amino acids (the ... functioning best at moderate temperatures and being adapted to ...
... 20 and older has risen from about 5.1 percent to ... Health (NIH) and the Centers for Disease Control and Prevention ... 1994 and 1999 to 2002. However, the percentage of ... years studied. About 2.8 percent of U.S. adult--one-third of ...
... Lauren Gerson, MD, so overjoyed are they at hearing her ... eat chocolate. Indulge your passion for spicy cuisine. Drink red ... juice with breakfast and, what the heck, eat a grapefruit, ... evidence to support the notion that eating these foods will ...
Cached Biology News:Bacteria beat the heat 2One-third of adults with diabetes still don't know they have it 2One-third of adults with diabetes still don't know they have it 3One-third of adults with diabetes still don't know they have it 4Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 2Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 3Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 4
... Fully automated, GLP-compliant Facility , Galaxy LIMS, ... , Highly experienced scientists ,We offer individual ... or full plasmids for single or double ... used when the DNA of interest is ...
Great for biotinylating DNA/RNA probes...
Anti-Wnt-2 Polyclonal Antibody Description: 100 g purified goat polyclonal antibody. Reacts with human/mouse/rat. Tested in Western blot/IP/IHC. Research Focus: signal transduction Storage...
...
Biology Products: